Calton & Associates’s Stericycle Inc SRCL Stock Holding History

Calton & Associates’s Portfolio SRCL Stock Details SRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-595	Closed	-$41K	–	1323
2017 Q4	$41K	Buy	+595	New	+$40.4K	0.01%	732

Other funds holding SRCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

CCP

Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Calton & Associates's SRCL Position: Q1 2018 in Review

Calton & Associates sold out of Stericycle Inc (SRCL) in Q1 2018, closing a stake of 595 shares — an estimated $41K sold.

Calton & Associates first reported a position in SRCL in Q4 2017 and held it in 1 quarter. The position peaked at $41K in Q4 2017. 502 funds tracked by Wall St. Rank hold SRCL as of Q1 2018.

Calton & Associates reported no remaining Stericycle Inc position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 595 Stericycle Inc shares in Q1 2018, an estimated $41K.
Calton & Associates first reported a position in Stericycle Inc in Q4 2017 and held it in 1 quarter.
Calton & Associates's Stericycle Inc position peaked at $41K in Q4 2017.
502 funds tracked by Wall St. Rank held Stericycle Inc as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.